TY - JOUR
T1 - Raising knowledge and awareness of fragile x syndrome in serbia, georgia, and colombia
T2 - A model for other developing countries?
AU - Protic, Dragana
AU - Salcedo-Arellano, Maria Jimena
AU - Stojkovic, Maja
AU - Saldarriaga, Wilmar
AU - Vidal, Laura Alejandra Ávila
AU - Miller, Robert M.
AU - Tabatadze, Nazi
AU - Peric, Marina
AU - Hagerman, Randi
AU - Budimirovic, Dejan B.
N1 - Funding Information:
This research was supported by the Science Fund of the Republic of Serbia, Program DIASPORA, Grant No 6431806, Acronym PREMED-FRAX. This article was published with the financial support of the Science Fund of the Republic of Serbia. The authors of the publication are responsible for the content of this publication and this content does not express the attitudes of the Science Fund of the Republic of Serbia. We thank the Faculty of Medicine at the University of Belgrade, Faculty of Medicine at the Tbilisi State Medical University in Georgia, and the School of Medicine and Surgery at the Universidad del Valle for allowing us to conduct this study with their students.
Funding Information:
Acknowledgements: This research was supported by
Publisher Copyright:
© 2021.
PY - 2021/12
Y1 - 2021/12
N2 - Fragile X syndrome is the most common monogenetic cause of inherited intellectual disability and syndromic autism spectrum disorder. Fragile X syndrome is caused by an expansion (full mutation ≥200 CGGs repeats, normal 10-45 CGGs) of the fragile X mental retardation 1 (FMR1) gene, epigenetic silencing of the gene, which leads to reduction or lack of the gene’s product: the fragile X mental retardation protein. In this cross-sectional study, we assessed general and pharmacotherapy knowledge (GK and PTK) of fragile X syndrome and satisfaction with education in neurodevelopmental disorders (NDDs) among senior medical students in Serbia (N=348), Georgia (N=112), and Colombia (N=58). A self-administered 18-item questionnaire included GK (8/18) and PTK (7/18) components and self-assessment of the participants education in NDDs (3/18). Roughly 1 in 5 respondents had correct answers on half or more facts about fragile X syndrome (GK>PTK), which ranged similarly 5-7 in Serbia, 6-8 in Georgia, and 5-8 in Colombia, respectively. No cohort had an average value greater than 9 (60%) that would represent passing score “cut-off.” None of the participants answered all the questions correctly. More than two-thirds of the participants concluded that they gained inadequate knowledge of NDDs during their studies, and that their education in this field should be more intense. In conclusion, there is a major gap in knowledge regarding fragile X syndrome among senior medical students in these three developing countries. The finding could at least in part be generalized to other developing countries aimed toward increasing knowledge and awareness of NDDs and fostering an institutional collaboration between developed and developing countries.
AB - Fragile X syndrome is the most common monogenetic cause of inherited intellectual disability and syndromic autism spectrum disorder. Fragile X syndrome is caused by an expansion (full mutation ≥200 CGGs repeats, normal 10-45 CGGs) of the fragile X mental retardation 1 (FMR1) gene, epigenetic silencing of the gene, which leads to reduction or lack of the gene’s product: the fragile X mental retardation protein. In this cross-sectional study, we assessed general and pharmacotherapy knowledge (GK and PTK) of fragile X syndrome and satisfaction with education in neurodevelopmental disorders (NDDs) among senior medical students in Serbia (N=348), Georgia (N=112), and Colombia (N=58). A self-administered 18-item questionnaire included GK (8/18) and PTK (7/18) components and self-assessment of the participants education in NDDs (3/18). Roughly 1 in 5 respondents had correct answers on half or more facts about fragile X syndrome (GK>PTK), which ranged similarly 5-7 in Serbia, 6-8 in Georgia, and 5-8 in Colombia, respectively. No cohort had an average value greater than 9 (60%) that would represent passing score “cut-off.” None of the participants answered all the questions correctly. More than two-thirds of the participants concluded that they gained inadequate knowledge of NDDs during their studies, and that their education in this field should be more intense. In conclusion, there is a major gap in knowledge regarding fragile X syndrome among senior medical students in these three developing countries. The finding could at least in part be generalized to other developing countries aimed toward increasing knowledge and awareness of NDDs and fostering an institutional collaboration between developed and developing countries.
KW - Developing countries
KW - Fragile X syndrome
KW - Knowledge and awareness
KW - Medical collaboration
UR - http://www.scopus.com/inward/record.url?scp=85121999647&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85121999647&partnerID=8YFLogxK
M3 - Article
C2 - 34970093
AN - SCOPUS:85121999647
SN - 0044-0086
VL - 94
SP - 559
EP - 571
JO - Yale Journal of Biology and Medicine
JF - Yale Journal of Biology and Medicine
IS - 4
ER -